BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20196948)

  • 1. [The effects of different PAP domains on hepatitis B virus replication].
    Guo CX; He YW; Peng C; Lei YC; Li WT
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insertion of TC motif into hepatitis B virus core protein c/e1 site does not affect the expression of S and e antigen].
    Lin YY; Cheng XM; Song YH; Chang Y; Yao JJ; Lin JS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):585-8. PubMed ID: 19719915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
    He YW; Guo CX; Pan YF; Peng C; Weng ZH
    World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
    Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of whole-genome lamivudine-resistant hepatitis B virus mutant and its replication and expression in HepG2 cells].
    Sun J; Wang C; Wen SJ; Wang ZH; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):991-3. PubMed ID: 17666334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HBV effect of sulfated polysaccharides from seaweed both in vitro and in vivo].
    Wei W; Cong J; Wang M; Teng L; Li Z; Chen H; Wu K; Sun C
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):112. PubMed ID: 11983127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of hepatitis B virus (HBV) replication using antisense LNA targeting to both S and C genes in HBV].
    Deng YB; Nong LG; Huang W; Pang GG; Wang YF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):900-4. PubMed ID: 20038330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
    He W; Li LX; Liao QJ; Liu CL; Chen XL
    World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
    Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
    Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
    Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
    J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibiting effects of the ethanol-soluble extracts from the dried rhizoma of Garcinia oblougififolia on hepatitis B virus in vitro].
    Yu Z; Chen W; Zheng Y
    Zhong Yao Cai; 1999 Mar; 22(3):142-3. PubMed ID: 12575099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy for chronic hepatitis B.
    Jafri SM; Lok AS
    Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the antiviral effects of different interferon alpha subtypes against hepatitis B virus].
    Lu NF; Huang AL; Zheng RQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):68-9. PubMed ID: 19203459
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
    Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
    J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
    McMillan JS; Shaw T; Angus PW; Locarnini SA
    Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.